Schizophrenia News

The Wyss Institute for Biologically Inspired Engineering at Harvard University recently announced a cross-institutional consortium to map neural circuits within the brain to improve understanding of neuropathological disorders.

Recent findings indicated vitamin B12 levels in the brain decrease with aging and are lower in individuals with autism or schizophrenia, compared with age-matched healthy controls.

Continued cannabis use after psychosis onset increased risk for psychosis relapse and led to longer hospital admissions and other adverse outcomes, according to a meta-analysis.

Individuals with schizotypal personality disorder exhibited increased activation in brain regions related to reward and decision making when viewing biological motion stimuli, which may be related to their social behavior.

There were no prognostic differences in risk for psychotic recurrence between individuals with acute and transient psychotic disorder, brief psychotic disorder, brief intermittent psychotic symptoms, or brief limited intermittent psychotic symptoms, according to a meta-analysis.

Boehringer Ingelheim and Arena Pharmaceuticals Inc. recently announced they have entered an executive agreement to conduct research to identify drug candidates targeting a G protein-coupled receptor belonging to the group of orphan central nervous system receptors.

High risk for psychosis was associated with increased resting activity in the hippocampus, midbrain and basal ganglia, and subsequent resolution of high-risk state was associated with normalization of activity in these areas.

Recent findings show a significant association between in vivo glutamatergic measurements, auditory mismatch negativity and verbal working memory in schizophrenia.

Recent findings suggest that activity in striatal regions of the reward system is associated with individual variability in the predisposition for weight gain related to antipsychotics.

Cognitive impairment differed between adults who experienced psychosis and those with psychotic disorders, suggesting differences between subclinical and clinical psychosis, according to recent findings.